Heat shock protein function as a target for anticancer drug discovery.

被引:0
|
作者
Whitesell, L
Hoy, S
Marron, M
Beroza, P
机构
[1] Telik Inc, S San Francisco, CA USA
[2] Univ Arizona, Tucson, AZ USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
203
引用
收藏
页码:3693S / 3693S
页数:1
相关论文
共 50 条
  • [31] Heat shock protein 90 as a potential drug target against surra
    Rochani, Ankit K.
    Mithra, Chandan
    Singh, Meetali
    Tatu, Utpal
    PARASITOLOGY, 2014, 141 (09) : 1148 - 1155
  • [32] Anon invasive bioluminescent matrigel plug angiogenesis assay for in vivo anticancer drug discovery.
    Clarke, Philip A.
    Kumari, Rajendra
    McKenzie, Andrew J.
    Watson, Susan A.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3532S - 3532S
  • [33] Using the Heat-Shock Response To Discover Anticancer Compounds that Target Protein Homeostasis
    Santagata, Sandro
    Xu, Ya-ming
    Wijeratne, E. M. Kithsiri
    Kontnik, Renee
    Rooney, Christine
    Perley, Casey C.
    Kwon, Hyoungtae
    Clardy, Jon
    Kesari, Santosh
    Whitesell, Luke
    Lindquist, Susan
    Gunatilaka, A. A. Leslie
    ACS CHEMICAL BIOLOGY, 2012, 7 (02) : 339 - 348
  • [34] TELOMERE LENGTH MAINTENANCE AS A TARGET FOR ANTICANCER DRUG DISCOVERY
    Muniyappa, K.
    MEDICINAL CHEMISTRY RESEARCH, 2010, 19 : S28 - S29
  • [35] The Hedgehog signaling pathway as a target for anticancer drug discovery
    Borzillo, GV
    Lippa, B
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (02) : 147 - 157
  • [36] New animal models in target discovery.
    Oosting, RS
    Stark, KL
    Hen, R
    van Scharrenburg, GJM
    TRENDS IN DRUG RESEARCH II, 1998, 29 : 203 - 213
  • [37] Molecular characterization of human tumor xenografts for target-oriented drug discovery.
    Burger, AM
    Willmann, H
    Stappert, H
    Fiebig, HH
    CLINICAL CANCER RESEARCH, 1999, 5 : 3875S - 3875S
  • [38] Target based Antibacterial Drug Discovery. Zero for the 20th Century
    Projan, Steven Jay
    FASEB JOURNAL, 2008, 22
  • [39] Genetically engineered human tumor cells as models for target validation and drug discovery.
    Finney, RE
    Lofquist, A
    Hagios, C
    Wang, N
    Ardourel, D
    Gurgel, J
    Balantac, N
    Calavetta, L
    Girard, E
    Rosler, R
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6127S - 6127S
  • [40] Role of contemporary drug metabolism in drug discovery.
    Baillie, TA
    CHEMICAL RESEARCH IN TOXICOLOGY, 2005, 18 (12) : 1969 - 1969